200 related articles for article (PubMed ID: 9746582)
1. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
Infect Immun; 1998 Oct; 66(10):4804-10. PubMed ID: 9746582
[TBL] [Abstract][Full Text] [Related]
2. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
J Exp Med; 1997 Jun; 185(11):1951-8. PubMed ID: 9166424
[TBL] [Abstract][Full Text] [Related]
3. Identification of S-(2,3-dihydroxypropyl)cystein in a macrophage-activating lipopeptide from Mycoplasma fermentans.
Mühlradt PF; Meyer H; Jansen R
Biochemistry; 1996 Jun; 35(24):7781-6. PubMed ID: 8672478
[TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear factor-kappaB in macrophages by mycoplasmal lipopeptides.
Sacht G; Märten A; Deiters U; Süssmuth R; Jung G; Wingender E; Mühlradt PF
Eur J Immunol; 1998 Dec; 28(12):4207-12. PubMed ID: 9862357
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
Lührmann A; Deiters U; Skokowa J; Hanke M; Gessner JE; Mühlradt PF; Pabst R; Tschernig T
Infect Immun; 2002 Jul; 70(7):3785-92. PubMed ID: 12065522
[TBL] [Abstract][Full Text] [Related]
7. The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.
Rosengarten R; Wise KS
J Bacteriol; 1991 Aug; 173(15):4782-93. PubMed ID: 1856172
[TBL] [Abstract][Full Text] [Related]
8. Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.
Davis KL; Wise KS
Infect Immun; 2002 Mar; 70(3):1129-35. PubMed ID: 11854192
[TBL] [Abstract][Full Text] [Related]
9. Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.
Calcutt MJ; Kim MF; Karpas AB; Mühlradt PF; Wise KS
Infect Immun; 1999 Feb; 67(2):760-71. PubMed ID: 9916088
[TBL] [Abstract][Full Text] [Related]
10. Activation of NLRP3 inflammasome in macrophages by mycoplasmal lipoproteins and lipopeptides.
Saeki A; Sugiyama M; Hasebe A; Suzuki T; Shibata K
Mol Oral Microbiol; 2018 Aug; 33(4):300-311. PubMed ID: 29682880
[TBL] [Abstract][Full Text] [Related]
11. Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice.
Deiters U; Mühlradt PF
Infect Immun; 1999 Jul; 67(7):3390-8. PubMed ID: 10377117
[TBL] [Abstract][Full Text] [Related]
12. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages.
Radolf JD; Arndt LL; Akins DR; Curetty LL; Levi ME; Shen Y; Davis LS; Norgard MV
J Immunol; 1995 Mar; 154(6):2866-77. PubMed ID: 7876555
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions.
Nishiguchi M; Matsumoto M; Takao T; Hoshino M; Shimonishi Y; Tsuji S; Begum NA; Takeuchi O; Akira S; Toyoshima K; Seya T
J Immunol; 2001 Feb; 166(4):2610-6. PubMed ID: 11160323
[TBL] [Abstract][Full Text] [Related]
14. In vivo immunomodulation by Mycoplasma fermentans membrane lipoprotein.
Romero F; Moreno E; Ruiz-Bravo A; Jiménez-Valera M
Curr Microbiol; 2004 Mar; 48(3):237-9. PubMed ID: 15057472
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
[TBL] [Abstract][Full Text] [Related]
17. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6.
Okusawa T; Fujita M; Nakamura J; Into T; Yasuda M; Yoshimura A; Hara Y; Hasebe A; Golenbock DT; Morita M; Kuroki Y; Ogawa T; Shibata K
Infect Immun; 2004 Mar; 72(3):1657-65. PubMed ID: 14977973
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
[TBL] [Abstract][Full Text] [Related]
19. Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy) heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages, and adjuvanticity in vivo and in vitro.
Metzger J; Jung G; Bessler WG; Hoffmann P; Strecker M; Lieberknecht A; Schmidt U
J Med Chem; 1991 Jul; 34(7):1969-74. PubMed ID: 2066969
[TBL] [Abstract][Full Text] [Related]
20. Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.
Piec G; Mirkovitch J; Palacio S; Mühlradt PF; Felix R
Infect Immun; 1999 Dec; 67(12):6281-5. PubMed ID: 10569738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
